Radar Therapeutics is a biotech company developing programmable precision therapeutics. Leveraging innovative mRNA technology and proprietary regulatory control elements, the company aims to revolutionize medicine by enabling targeted, timely, and controlled therapeutic interventions. Radar is committed to advancing the boundaries of genetic medicine to address unmet medical needs and improve patient access.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 05/23/24 | $13,400,000 | Seed |
BEVC Biovision Ventures Eli Lilly and Company KdT Ventures NfX Bio  PearVC | undisclosed |
